MELISSA HODGES: Open Payments
NPI 1942824594 · BRANDON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,485 in 88 payments from 19 companies in 2025. Trend: 2023 $1,867 · 2024 $2,061 · 2025 $3,485
Food & beverage: $3,385Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 14 | $752 |
| ABBVIE INC. | 18 | $627 |
| Arcutis Biotherapeutics, Inc. | 10 | $535 |
| Botanix SB Inc | 4 | $314 |
| GlaxoSmithKline, LLC. | 14 | $222 |
| Galderma Laboratories, L.P. | 6 | $190 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $173 |
| UCB, Inc. | 2 | $149 |
| Lilly USA, LLC | 1 | $125 |
| Novartis Pharmaceuticals Corporation | 4 | $115 |
Products named: TREMFYA, Zoryve, SKYRIZI, SOFDRA, NUCALA, NEMLUVIO, Bimzelx, Winlevi.
Industry payments across FL — which companies pay providers there.
